Startup

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

The True Post icon
By The True Post
No Comments
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

Source: TechCrunch Startups

TAGGED:
Share This Article
The True Post icon
ByThe True Post
The newsroom of The True Post.
Leave a Comment

Related Stories

Uncover the stories that related to the post!
Virginia governor creates an AI task force and moves to restrain data centers
Technology

Virginia governor creates an AI task force and moves to restrain data centers

Family offices are clamoring for AI investments
Technology

Family offices are clamoring for AI investments

Is the AI industry really ready to slow down?
Technology

Is the AI industry really ready to slow down?

Databricks buys Row Zero and is scouting for more startups to acquire
Technology

Databricks buys Row Zero and is scouting for more startups to acquire

Anthropic has set up a bio research lab for physical experiments
Technology

Anthropic has set up a bio research lab for physical experiments

Modal Motors is trying to cut China out of electric motors entirely
Technology

Modal Motors is trying to cut China out of electric motors entirely

A new kind of AI model from a ChatGPT inventor is thrilling developers
Technology

A new kind of AI model from a ChatGPT inventor is thrilling developers

Instinct’s powerful AI assistant is raising privacy and security concerns
Technology

Instinct’s powerful AI assistant is raising privacy and security concerns

Show More